BioCentury | Oct 21, 2013
Company News

iCeutica management update

...Philadelphia, Pa. Business: Drug delivery Hired: Jyrki Mattila as CBO, formerly president and CEO of LZ Therapeutics Inc. WIR...
BioCentury | Mar 8, 2012
Cover Story

Working on the brain gang(lioside)

...lipid rafts, though the significance of these associations is unclear. Schneider is the founder of LZ Therapeutics Inc....
...a larger Phase II PD trial for which he hopes to obtain NIH funding. Meanwhile, LZ Therapeutics...
...and is developing LZT-1000 , a formulation of GM1, for PD and other neurological disorders. LZ Therapeutics...
Items per page:
1 - 2 of 2
BioCentury | Oct 21, 2013
Company News

iCeutica management update

...Philadelphia, Pa. Business: Drug delivery Hired: Jyrki Mattila as CBO, formerly president and CEO of LZ Therapeutics Inc. WIR...
BioCentury | Mar 8, 2012
Cover Story

Working on the brain gang(lioside)

...lipid rafts, though the significance of these associations is unclear. Schneider is the founder of LZ Therapeutics Inc....
...a larger Phase II PD trial for which he hopes to obtain NIH funding. Meanwhile, LZ Therapeutics...
...and is developing LZT-1000 , a formulation of GM1, for PD and other neurological disorders. LZ Therapeutics...
Items per page:
1 - 2 of 2